OPQ - Agilent OpenLab Software for Labs
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- Points of contact
-
- Christopher Scott christopher.scott@fda.hhs.gov
- tbd@fda.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration (FDA) is forecasting a new requirement for OpenLab Software licenses for OPQ laboratories (OLSMA), classified under the Software and Other Prerecorded Compact Disc, Tape, and Record Reproducing NAICS code 334614. The estimated solicitation release date is March 1, 2026, with an anticipated contract award date of May 1, 2026. This procurement appears to focus on providing specialized software licensing for laboratory operations within the FDA's OPQ division.
The primary point of contact for this opportunity is Christopher Scott, who can be reached at christopher.scott@fda.hhs.gov from the Food and Drug Administration. While specific award values, quantities, and performance locations are not currently detailed in the forecast, interested vendors should note that this is not a set-aside contract, suggesting open competition. Potential bidders are advised to monitor the solicitation closely, as additional details are expected to be released closer to the estimated solicitation date in March 2026.
Forecast text
OpenLab Software licenses for OPQ laboratories OLSMA
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast